← Leaderboards
Dipanjan Pan
Washington University
$1,633,276
Attributed
$4,466,826
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,466,826 · 5
By mechanism
R01$3,793,730 · 3
R43$373,216 · 1
R03$299,880 · 1
Top collaborators
- Gregory M Lanza5 shared
- Katherine Nelson Weilbaecher5 shared
- Esma Alp1 shared
- Narayana Aluru1 shared
- Paul Werner Buehler1 shared
- Allan Doctor1 shared
- Casey N Pinto1 shared
- Carla Rafferty1 shared
Most similar at Washington University
Same institution · by research overlap
- Jai Rudra$4,772,528
- Erica Lynn Scheller$4,956,669
- Michael Dennis Raleigh$186,534
Others in their field
Top investigators on “Clinic”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,108,147,906
- Leonard Freedman · Leidos Biomedical Research, Inc.$978,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$798,941,641
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$639,436,363
- Barton F Haynes · Duke University$546,907,423
Research focus
ClinicResistanceLocationBaseResponseExhibitsOryctolagus CuniculusTumorNanoparticleDesignBiologicalTreatment ResponseAdverse EffectsAcuteDensityImageAreaAdjuvant TherapyBloodClinical TrialsBisphosphonateCompare EffectivenessCost EffectiveAngiogenic Factor
Grant awards (12)
Preclinical Evaluation of a Peptide-amphiphile Derived Toroidal Oxygen Carrier$715,110
R01 · FY2025 · HL · contact PI
An integrated multiplexed diagnostic assay targeting fusion lipoproteins and cardiolipin for detection of treponemal and nontreponemal antibodies in syphilis patients$698,349
R01 · FY2025 · AI · contact PI
Rapid Reconstitution of a Lyophilized, Bio-inspired, Artificial Red Blood Cell$373,216
R43 · FY2020 · HL
A radioopaque temporary embolic agent for surgical application$76,500
R03 · FY2020 · EB · contact PI
A Sensing Platform for Rapid at Home-Test of COVID-19$76,500
R03 · FY2020 · EB · contact PI
A Highly Specific Point-of-Care Rapid Real-time Sensing Device for COVID-19$70,380
R03 · FY2020 · EB · contact PI
A radioopaque temporary embolic agent for surgical application$76,500
R03 · FY2019 · EB · contact PI
NEXT GENERATION APPROACHES TO BREAST CANCER USING IMAGE GUIDED DRUG DELIVERY$482,398
R01 · FY2015 · CA
NEXT GENERATION APPROACHES TO BREAST CANCER USING IMAGE GUIDED DRUG DELIVERY$469,056
R01 · FY2014 · CA
NEXT GENERATION APPROACHES TO BREAST CANCER USING IMAGE GUIDED DRUG DELIVERY$455,665
R01 · FY2013 · CA
NEXT GENERATION APPROACHES TO BREAST CANCER USING IMAGE GUIDED DRUG DELIVERY$485,959
R01 · FY2012 · CA
NEXT GENERATION APPROACHES TO BREAST CANCER USING IMAGE GUIDED DRUG DELIVERY$487,193
R01 · FY2011 · CA